SIRT3 provides protection against cardiac hypertrophy, dyslipidaemia and cardiomyopathy [8], however, genetic ablation of SIRT3 have no impact on atherogenesis [61], suggesting distinctive effects of different sirtuins in atherosclerosis. This evidence concerns the gene SIRT3 and cardiac hypertrophy.